Cortex Pharmaceuticals Inc.: The Irvine drug development...

Cortex Pharmaceuticals Inc.: The Irvine drug development company posted a loss of $1.5 million, or 5 cents a share, for its first fiscal quarter, which ended Sept. 30. That compared to a loss of $875,805, or 5 cents share, for the same period a year earlier. The company reported no revenue.